This program reviews current knowledge in the safety and best practices in minimally invasive surgery; particularly surgical approaches to laparoscopy, fluid management, and electrosurgery in gynaecology. This program supports specialists in gynaecology in their knowledge of these aspects of minimally invasive surgery with an individualized understanding of patient risks and benefits. |
This online course will give you the opportunity to evaluate twenty cases of women seeking contraception. These will present common and not-so-common situations that may face health care providers. |
The objectives of this course are to allow participants to review the epidemiology of HPV and disease, to update the latest data on HPV vaccines, to discuss the uptake of HPV vaccination and its impact on disease, to explore the safety of HPV vaccines, and to learn how to successfully counsel on HPV vaccination. |
The objectives of this course are to allow participants to review the rational of using aromatase inhibitor in infertility, to update the latest data on letrozole, to discuss indications and safety of letrozole treatment, to discuss how to use letrozole in infertility and to learn how to counsel the patients about letrozole treatment. |
While comprehensive evidence-based guidelines exist to guide choices in induction of labour (IOL), the practice of IOL involves specific safety considerations, accurate methods of administration, skilled patient counselling, documentation, and clinical judgement. This CME program supports hospital obstetrics staff with up-to-date education on safety matters concerning induction of labour (IOL), including methods, risks, and practical insights for optimal safety. |
By the end of this program, participants should be able to define medical abortion, to describe the incidence of both induced abortion and medical abortion in Canada, to identify differences in abortion access between and within the provinces and territories of Canada and to understand the need for a combination regimen of mifepristone/misoprostol in Canada. |
The medical management of uterine fibroids is an evolving practice. As novel therapies are introduced, clinical practice guidance has been updated to provide evidence-based recommendations on the evolving role of these agents in clinical practice. This program reviews the role of medical therapy in the management of uterine fibroids. The Society of Obstetricians and Gynaecologists of Canada (SOGC) provides guidance for The Management of Uterine Leiomyomas (SOGC CPG #318). Additional SOGC guidance of relevance to this topic includes: Abnormal Uterine Bleeding in Pre-Menopausal Women, and The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility. “Until recently, medical management options for uterine leiomyomas have been of limited value because of their moderate efficacy and/or associated adverse effects. Novel therapies at the receptor and gene levels have emerged or are undergoing investigation and may eventually offer better long-term management options.” (SOGC Clinical Practice Guideline #318) |
As the population ages, women with menopausal symptoms make up an increasing proportion of the population. Vasomotor and vaginal symptoms in menopause are common. Additionally, menopause is associated with other changes including decreased bone density, joint pain, sleep disturbance and increased cardiovascular risk. Overall, menopause can affect quality of life, sexuality, self-image, and health status. It is important to ask women if they are experiencing symptoms, since many may think that menopausal symptoms are just a natural consequence of menopause and something they must suffer through. Many may also mistakenly feel that therapy is not an option due to safety concerns. The scientific evidence and the therapeutic options have changed since WHI. This program supports physicians with the individualized management of menopause-related symptoms and conditions, in accordance with SOGC clinical practice guidelines, for improved patient outcomes. |
After completing this course, learners will be able to describe the evidence for efficacy and safety of vaccination during pregnancy and the preconception and postpartum periods, to identify the indications and contraindications for various vaccines including travel vaccines during pregnancy and the preconception and postpartum periods, to demonstrate strategies to counsel patients about vaccination during pregnancy, to recognize reasons why patients choose not to vaccinate during pregnancy, to develop an approach to respond to severe adverse reactions associated with vaccinations in pregnancy such as anaphylaxis, and to describe the protocols for safe vaccine storage, handling, and administration. |